The Situation
A Top 10 pharmaceutical company with a diverse portfolio in hematology faced challenges in accessing contextualized, actionable competitive insights for brand teams across five distinct disease areas. Previous vendors had fallen short of delivering value, leaving gaps in decision-making and strategic alignment.
The Solution
Sedulo launched a long-term global Early Warning Monitoring Program to equip stakeholders with validated, relevant intelligence. The program spanned clinical, commercial, and regulatory focus areas and was tailored to each disease state.
Real-Time Email Alerts: Delivered timely, actionable insights on competitor activity and market shifts.
Ongoing Primary Intelligence: Conducted in-depth research into competitor strategies, including launch plans, commercialization, and regulatory developments.
Workshops: Facilitated competitive strategy workshops to drive cross-functional alignment and decision-making.
Landscape Reports: Delivered in-depth, insights-driven reports for each indication, analyzing competitor positioning and market dynamics.
Conference Intelligence: Provided onsite coverage of EHA, ASH, and other key meetings, delivering critical insights from sessions and stakeholder engagement.
The Success
With Sedulo’s support, the client aligned its CI function with the needs of the individual brand teams and decision-makers. The comprehensive research, analysis, and facilitated engagement gave each team the insights they needed, including:
- A deep understanding of evolving market dynamics
- Awareness of competitor positioning and strategic intent
- Identification of risks and opportunities across five Heme indications
Sedulo’s partnership ensured the client remained strategically informed, competitively prepared, and better equipped to navigate market complexity.